Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1983 Dec;80(23):7215–7218. doi: 10.1073/pnas.80.23.7215

Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro.

A P Gee, M D Boyle, K L Munger, M J Lawman, M Young
PMCID: PMC390025  PMID: 6580641

Abstract

Topical application of mouse nerve growth factor (NGF) to superficial skin wounds of mice has previously been shown to accelerate the rate of wound contraction. Results of the present study reveal that NGF in the presence of plasma is also chemotactic for human polymorphonuclear leukocytes in vitro, and the concentration of NGF required for this effect is similar to that which stimulates ganglionic neurite outgrowth. This property does not arise from liberation of the C5a fragment of complement, nor does it require the known enzymic activity of NGF. (NGF inactivated with diisopropyl fluorophosphate is equally active.) We conclude that NGF can display biological effects on cells of nonneural origin and function, and this feature might play a role in the early inflammatory response to injury.

Full text

PDF
7215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar-Shavit R., Kahn A., Fenton J. W., 2nd, Wilner G. D. Chemotactic response of monocytes to thrombin. J Cell Biol. 1983 Jan;96(1):282–285. doi: 10.1083/jcb.96.1.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bar-Shavit R., Kahn A., Wilner G. D., Fenton J. W., 2nd Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science. 1983 May 13;220(4598):728–731. doi: 10.1126/science.6836310. [DOI] [PubMed] [Google Scholar]
  3. Boyle M. D., Young M. Nerve growth factor: activation of the classical complement pathway by specific substitution for component C1-. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2519–2522. doi: 10.1073/pnas.79.8.2519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deuel T. F., Senior R. M., Chang D., Griffin G. L., Heinrikson R. L., Kaiser E. T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4584–4587. doi: 10.1073/pnas.78.7.4584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deuel T. F., Senior R. M., Huang J. S., Griffin G. L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982 Apr;69(4):1046–1049. doi: 10.1172/JCI110509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Donabedian H., Gallin J. I. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe. J Immunol. 1981 Sep;127(3):839–844. [PubMed] [Google Scholar]
  7. Fernandez H. N., Henson P. M., Otani A., Hugli T. E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol. 1978 Jan;120(1):109–115. [PubMed] [Google Scholar]
  8. Fernandez H. N., Hugli T. E. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol. 1976 Nov;117(5 Pt 1):1688–1694. [PubMed] [Google Scholar]
  9. Greene L. A., Shooter E. M., Varon S. Enzymatic activities of mouse nerve growth factor and its subunits. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1383–1388. doi: 10.1073/pnas.60.4.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LEVI-MONTALCINI R., HAMBURGER V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951 Mar;116(2):321–361. doi: 10.1002/jez.1401160206. [DOI] [PubMed] [Google Scholar]
  11. Levi-Montalcini R. Developmental neurobiology and the natural history of nerve growth factor. Annu Rev Neurosci. 1982;5:341–362. doi: 10.1146/annurev.ne.05.030182.002013. [DOI] [PubMed] [Google Scholar]
  12. Li A. K., Koroly M. J., Schattenkerk M. E., Malt R. A., Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4379–4381. doi: 10.1073/pnas.77.7.4379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murphy R. A., Saide J. D., Blanchard M. H., Young M. Molecular properties of the nerve growth factor secreted in mouse saliva. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2672–2676. doi: 10.1073/pnas.74.7.2672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murphy R. A., Saide J. D., Blanchard M. H., Young M. Nerve growth factor in mouse serum and saliva: role of the submandibular gland. Proc Natl Acad Sci U S A. 1977 Jun;74(6):2330–2333. doi: 10.1073/pnas.74.6.2330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Orenstein N. S., Dvorak H. F., Blanchard M. H., Young M. Nerve growth factor: a protease that can activate plasminogen. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5497–5500. doi: 10.1073/pnas.75.11.5497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pattison S. E., Dunn M. F. On the relationship of zinc ion to the structure and function of the 7S nerve growth factor protein. Biochemistry. 1975 Jun 17;14(12):2733–2739. doi: 10.1021/bi00683a027. [DOI] [PubMed] [Google Scholar]
  17. Rosenfeld S. I., Kelly M. E., Leddy J. P. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies. J Clin Invest. 1976 Jun;57(6):1626–1634. doi: 10.1172/JCI108433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Showell H. J., Freer R. J., Zigmond S. H., Schiffmann E., Aswanikumar S., Corcoran B., Becker E. L. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med. 1976 May 1;143(5):1154–1169. doi: 10.1084/jem.143.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wallace L. J., Partlow L. M. alpha-Adrenergic regulation of secretion of mouse saliva rich in nerve growth factor. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4210–4214. doi: 10.1073/pnas.73.11.4210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ward P. A., Newman L. J. A neutrophil chemotactic factor from human C'5. J Immunol. 1969 Jan;102(1):93–99. [PubMed] [Google Scholar]
  21. Young M., Koroly M. J. Nerve growth factor zymogen. Stoichiometry of the active-site serine and role of zinc(II) in controlling autocatalytic self-activation. Biochemistry. 1980 Nov 11;19(23):5316–5321. doi: 10.1021/bi00564a026. [DOI] [PubMed] [Google Scholar]
  22. Young M., Oger J., Blanchard M. H., Asdourian H., Amos H., Arnason B. G. Secretion of a nerve growth factor by primary chick fibroblast cultures. Science. 1975 Jan 31;187(4174):361–362. doi: 10.1126/science.1167427. [DOI] [PubMed] [Google Scholar]
  23. Young M. Proteolytic activity of nerve growth factor: a case of autocatalytic activation. Biochemistry. 1979 Jul 10;18(14):3050–3055. doi: 10.1021/bi00581a022. [DOI] [PubMed] [Google Scholar]
  24. Young M., Saide J. D., Murphy R. A., Blanchard Nerve growth factor: multiple dissociation products in homogenates of the mouse submandibular gland. Purification and molecular properties of the intact undissociated form of the protein. Biochemistry. 1978 Apr 18;17(8):1490–1498. doi: 10.1021/bi00601a021. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES